食品添加剂乳化剂与2型糖尿病风险:NutriNet-Santé前瞻性队列研究数据分析
该研究分析法国NutriNet-Santé前瞻性队列104139名成人(2009年5月1日至2023年4月26日入组,平均年龄42.7岁),通过重复24小时膳食记录评估食品添加剂乳化剂暴露,随访平均6.8年期间1056人诊断为2型糖尿病;多种乳化剂摄入与2型糖尿病风险呈正相关,作者认为需进一步研究以推动重新评估食品工业中添加剂乳化剂的使用法规。
要点
- 总卡拉胶每增加100 mg/天,2型糖尿病风险HR 1.03(95%CI 1.01-1.05),p<0.0001。
- 瓜尔胶(E412)每增加500 mg/天,HR 1.11(95%CI 1.06-1.17),p<0.0001。
- 黄原胶(E415)每增加500 mg/天,HR 1.08(95%CI 1.02-1.14),p=0.013。
核心结论
- 在法国成人大型前瞻性队列中,多种广泛用于工业食品的食品添加剂乳化剂暴露与2型糖尿病风险呈直接关联。
- 作者认为需进一步研究以推动重新评估食品工业中添加剂乳化剂的使用法规,以更好保护消费者。
研究设计与样本
- 研究分析法国NutriNet-Santé前瞻性队列研究数据,纳入2009年5月1日至2023年4月26日入组的104139名成人,其中82456名(79.2%)为女性,平均年龄42.7岁(SD 14.5)。
- 膳食摄入通过每6个月连续3个非连续日采集的3份24小时膳食记录评估。
- 添加剂乳化剂暴露通过多个食物成分数据库和专门实验室检测评估。
- 采用多变量比例风险Cox模型分析累积时间依赖性暴露与2型糖尿病风险的关联,并校正已知危险因素。
- NutriNet-Santé研究在ClinicalTrials.gov注册(NCT03335644)。
主要发现
- 104139名参与者中,随访期间1056人诊断为2型糖尿病,平均随访时长6.8年(SD 3.7)。
- 总卡拉胶每增加100 mg/天,2型糖尿病风险HR 1.03(95%CI 1.01-1.05),p<0.0001;卡拉胶胶(E407)每增加100 mg/天,HR 1.03(95%CI 1.01-1.05),p<0.0001。
- 磷酸三钾(E340)每增加500 mg/天,HR 1.15(95%CI 1.02-1.31),p=0.023;脂肪酸单甘油酯和双甘油酯乙酰酒石酸酯(E472e)每增加100 mg/天,HR 1.04(95%CI 1.00-1.08),p=0.042。
- 柠檬酸钠(E331)每增加500 mg/天,HR 1.04(95%CI 1.01-1.07),p=0.0080;瓜尔胶(E412)每增加500 mg/天,HR 1.11(95%CI 1.06-1.17),p<0.0001。
- 阿拉伯胶(E414)每增加1000 mg/天,HR 1.03(95%CI 1.01-1.05),p=0.013;黄原胶(E415)每增加500 mg/天,HR 1.08(95%CI 1.02-1.14),p=0.013。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Experimental studies have suggested potential detrimental effects of emulsifiers on gut microbiota, inflammation, and metabolic perturbations. We aimed to investigate the associations between exposures to food additive emulsifiers and the risk of type 2 diabetes in a large prospective cohort of French adults. METHODS: We analysed data from 104 139 adults enrolled in the French NutriNet-Santé prospective cohort study from May 1, 2009, to April 26, 2023; 82 456 (79·2%) were female and the mean age was 42·7 years (SD 14·5). Dietary intakes were assessed with three 24 h dietary records collected over three non-consecutive days, every 6 months. Exposure to additive emulsifiers was evaluated through multiple food composition databases and ad-hoc laboratory assays. Associations between cumulative time-dependent exposures to food additive emulsifiers and the risk of type 2 diabetes were characterised with multivariable proportional hazards Cox models adjusted for known risk factors. The NutriNet-Santé study is registered at ClinicalTrials.gov (NCT03335644). FINDINGS: Of 104 139 participants, 1056 were diagnosed with type 2 diabetes during follow-up (mean follow-up duration 6·8 years [SD 3·7]). Intakes of the following emulsifiers were associated with an increased risk of type 2 diabetes: total carrageenans (hazard ratio [HR] 1·03 [95% CI 1·01-1·05] per increment of 100 mg per day, p<0·0001), carrageenans gum (E407; HR 1·03 [1·01-1·05] per increment of 100 mg per day, p<0·0001), tripotassium phosphate (E340; HR 1·15 [1·02-1·31] per increment of 500 mg per day, p=0·023), acetyl tartaric acid esters of monoglycerides and diglycerides of fatty acids (E472e; HR 1·04 [1·00-1·08] per increment of 100 mg per day, p=0·042), sodium citrate (E331; HR 1·04 [1·01-1·07] per increment of 500 mg per day, p=0·0080), guar gum (E412; HR 1·11 [1·06-1·17] per increment of 500 mg per day, p<0·0001), gum arabic (E414; HR 1·03 [1·01-1·05] per increment of 1000 mg per day, p=0·013), and xanthan gum (E415, HR 1·08 [1·02-1·14] per increment of 500 mg per day, p=0·013). INTERPRETATION: We found direct associations between the risk of type 2 diabetes and exposures to various food additive emulsifiers widely used in industrial foods, in a large prospective cohort of French adults. Further research is needed to prompt re-evaluation of regulations governing the use of additive emulsifiers in the food industry for better consumer protection. FUNDING: European Research Council, French National Cancer Institute, French Ministry of Health, IdEx Université de Paris, and Bettencourt-Schueller Foundation.
引用
- Salame C, Javaux G, Sellem L, et al. Food additive emulsifiers and the risk of type 2 diabetes: analysis of data from the NutriNet-Santé prospective cohort study. Lancet Diabetes Endocrinol. 2024. PMID: 38663950. doi:10.1016/S2213-8587(24)00086-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。